Evidation community is an engaged “waiting room” for clinical research.
Access our community to:
Quickly enroll specific populations
Segment by condition, demographics and other key criteria matched to protocols among dozens of therapeutic areas
Reach underrepresented audiences
Increase diversity with coverage across 97% U.S. zip codes and segmentation by social determinants of health
Streamline recruitment and data collection
Target individuals based on algorithms to characterize health risks and likelihood of symptom incidence during the trial (such as flare ups, acute illness and more)
Migraine study
170
Participants recruited in 13 days
COVID-19 market research
100,000
Participants recruited in 5 weeks
Influenza clinical trial
28K+
Instances of flu-like symptoms from predictive model using digital health measures
1.1K+
Individuals referred to clinical trial for 2022-2023 flu season
Helping our partners accelerate and improve care
Evidation partners include nine of the top 10 biopharma companies in the world, as well as insurers, health systems, technology companies, academia, professional societies, and government agencies.